To protect the health and safety of the public and our employees, DCP employees will no longer be at 450 Columbus Blvd. Please do not send mail. We recommend using our online services, or sending an email to the appropriate division/person instead. Phone lines will have limited support, and voicemails will be returned when possible. We apologize for any inconvenience.

Press Releases

DCP Press Release Header

10/22/2019

New Conditions for Medical Marijuana Program Approved by Regulations Review Committee

Tuesday, October 22nd 2019– Today, the Regulations Review Committee of the General Assembly approved Department of Consumer Protection (DCP) Medical Marijuana Program regulations that include the addition of 5 new conditions for adults, and 2 new conditions for patients under 18. Those conditions are:

 

For Adults:

 

  • Interstitial Cystitis
  • MALS Syndrome (Median Arcuate Ligament Syndrome)
  • Vulvodynia and Vulvar Burning
  • Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments
  • Tourette Syndrome

 

Patients Under 18:

 

  • Intractable Neuropathic Pain that Is Unresponsive to Standard Medical Treatments
  • Tourette Syndrome for patients who have failed standard medical treatment

 

“I want to thank members of the Regulations Review Committee and our Board of Physicians for their consistently thoughtful consideration of these new conditions,” said Consumer Protection Commissioner Michelle H. Seagull, “I am pleased that more patients with severe debilitating conditions will now have medical marijuana as an option for treatment, and I look forward to continuing the Department’s work on this program.”

 

The last step in this process is for DCP to submit the regulations to the Secretary of the State's Office, who will post the regulations online. At that point, the regulations will be final.

 

There are currently 37,080 patients benefitting from the medical marijuana program, 1186 certifying physicians, and a new total of 36 conditions approved for adults and 10 for patients under 18.

 

For more information about the medical marijuana program, please visit www.ct.gov/DCP/mmp. Those with questions or concerns may email dcp.mmp@ct.gov.

 

###

 

Media Contact:
Lora Rae Anderson
lorarae.anderson@ct.gov
(860) 713-6019 (office)
(860) 247-8711 (cell)

Twitter: DCP on Twitter
Facebook: DCP on Facebook